三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

日韩中文字幕一区二区av| 九一国免费在线视频国产| 久久久久久九九69精品| 国产97在线| 欧美一区一区三区精品99| 偷拍自拍视频一区二区三区 | 欧美一区日韩二区国产综合| 大香蕉四姑娘天天操av| 亚洲美女高潮久久久久电影| 久久超碰激情网| 2022亚洲在线免费视频| 熟女天堂av一区二区三区| 无码精品久久久天天影视| 懂色人妻一区二区三区在线| 国产精品综合在线免费看| 久久夜色精品噜噜亚洲av| 国产亚洲曝欧美曝妖精品| 亚洲免费一区二区三区av| 国产精品久久久久久久精| 天堂√在线中文在线新版| 中文无码亚洲精品制服丝袜| 日本av亚洲欧美av二区| 午夜精品视频免费在线观看| 国产精品不卡无毒久久久久| 97国产精品无码第一区| 国产av午夜一区二区三区| 国产精品视频免费看久久久| 久久精品中文字幕一区| 久久人人爽天天玩人人妻精品| 久久夜色精品国产69乱| 小早川在线一区二区三区| 日韩精品三级片| 99精品国产成人一区二区| 欧美国产伦久久久久久久| 丰满少妇大力进入av亚洲| 青青青草原在线免费观看| 加勒比无码av中文字幕| 国产69精品久久久熟女| 久久久亚洲av日韩人妻| 久久久久久99999精品| 97影院秋霞午夜在线观看|